US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

5.17

+0.22004.44%

Post-market: 5.170.00000.00%19:30 EDT

Volume:82.57K

Turnover:424.85K

Market Cap:316.95M

PE:-3.89

High:5.23

Open:4.96

Low:4.94

Close:4.95

52wk High:7.95

52wk Low:2.20

Shares:61.31M

Float Shares:43.63M

Volume Ratio:0.84

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3300

EPS(LYR):-1.8389

ROE:-496.21%

ROA:-36.75%

PB:48.39

PE(LYR):-2.81

Loading ...

Overview Company News Filings

TriSalus Chief of Clinical Operations Devlin to retire Oct. 1

Press Release: TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call

TriSalus Life Sciences to host first-quarter financial results conference call

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TriSalus publishes investor presentation on pressure-enabled drug delivery for solid tumors

TriSalus to present new PEDD clinical, preclinical data at SIR 2026 meeting

TriSalus Life Sciences Appoints Richard Marshall, M.d., as Chief Medical Officer

THOMSON REUTERS

TriSalus names Richard Marshall chief medical officer effective June 29

TriSalus Life Sciences announces annual shareholder meeting notice and proxy statement

TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland

TriSalus Life Sciences reports preclinical study of PEDD-delivered nelitolimod in liver tumor models

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

TriSalus Life Sciences Publishes Investor Presentation on Pressure-Enabled Drug Delivery for Solid Tumors

TriSalus Life Sciences price target lowered to $7 from $12 at Canaccord

TriSalus posts Q4 revenue of USD 13.2 million up 60%

TriSalus Life Sciences Q4 Income From Operations USD -3.271 Million

THOMSON REUTERS

Press Release: TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/TLSI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLSI\",,,,,undefined,":{"symbol":"TLSI","market":"US","secType":"STK","nameCN":"TriSalus Life Sciences Inc.","latestPrice":5.17,"timestamp":1788292800000,"preClose":4.95,"halted":0,"volume":82574,"hourTrading":{"tag":"盘后","latestPrice":5.17,"preClose":5.17,"latestTime":"19:30 EDT","volume":1251,"amount":6480.99,"timestamp":1788305401051,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04444444444444439,"floatShares":43631202,"shares":61306437,"eps":-1.33,"marketStatus":"Closed","change":0.22,"latestTime":"09-01 16:00:00 EDT","open":4.96,"high":5.23,"low":4.935,"amount":424845.2365482,"amplitude":0.059596,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":4.95,"preHourTrading":{"tag":"盘前","latestPrice":4.95,"preClose":4.95,"latestTime":"08:18 EDT","volume":5,"amount":24.75,"timestamp":1788265130587,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.17,"preClose":5.17,"latestTime":"19:30 EDT","volume":1251,"amount":6480.99,"timestamp":1788305401051,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.835118},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLSI\",,,,,undefined,":{"symbol":"TLSI","floatShares":43631202,"roa":"-36.75%","roe":"-496.21%","lyrEps":-1.838893,"volumeRatio":0.835118,"shares":61306437,"dividePrice":0,"high":5.23,"amplitude":0.059596,"preClose":4.95,"low":4.935,"week52Low":2.2,"pbRate":"48.39","psRate":"7.03","week52High":7.95,"institutionHeld":0,"latestPrice":5.17,"eps":-1.33,"divideRate":0,"volume":82574,"delay":0,"ttmEps":-1.33,"open":4.96,"prevYearClose":6.98,"prevWeekClose":4.83,"prevMonthClose":4.95,"prevQuarterClose":4.55,"fiveDayClose":5.03,"twentyDayClose":4.74,"sixtyDayClose":3.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"TLSI","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2026-05-12","symbol":"TLSI","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2026-03-05","symbol":"TLSI","fiscalQuarterEnding":"2025/12","expectedEps":-0.13,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2026-01-12","symbol":"TLSI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-13","symbol":"TLSI","fiscalQuarterEnding":"2025/09","expectedEps":-0.17,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.96}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLSI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLSI\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1739505600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLSI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"TLSI","date":"2026-08-31","current":-3.887218,"percent":0.028571,"low":-12.527939,"twenty":-7.480474,"median":-5.43444,"eighty":-2.59357,"high":-1.950969,"avg":-5.330313,"sd":2.492168,"marketCap":297405318},"quantilePoints":[{"date":"2023-08-25","current":-3.951708,"twenty":-4.696261,"median":-4.538989,"eighty":-4.36181,"marketCap":208954447},{"date":"2023-09-01","current":-3.244979,"twenty":-4.556906,"median":-3.745164,"eighty":-3.316647,"marketCap":171584760},{"date":"2023-09-08","current":-2.543227,"twenty":-4.494197,"median":-3.351984,"eighty":-2.924463,"marketCap":134478239},{"date":"2023-09-15","current":-2.351614,"twenty":-4.156759,"median":-3.040924,"eighty":-2.399891,"marketCap":124346317},{"date":"2023-09-22","current":-2.782122,"twenty":-3.703855,"median":-2.807006,"eighty":-2.468573,"marketCap":147110246},{"date":"2023-09-29","current":-2.672628,"twenty":-3.43709,"median":-2.737329,"eighty":-2.513366,"marketCap":141320576},{"date":"2023-10-06","current":-2.418803,"twenty":-3.3485,"median":-2.63779,"eighty":-2.507394,"marketCap":127899069},{"date":"2023-10-13","current":-2.478527,"twenty":-3.280813,"median":-2.558158,"eighty":-2.463596,"marketCap":131057071},{"date":"2023-10-20","current":-2.378988,"twenty":-3.122546,"median":-2.540739,"eighty":-2.438711,"marketCap":125793735},{"date":"2023-10-27","current":-2.364057,"twenty":-3.040924,"median":-2.535762,"eighty":-2.42378,"marketCap":125004234},{"date":"2023-11-03","current":-2.045531,"twenty":-3.016039,"median":-2.52332,"eighty":-2.378988,"marketCap":108161558},{"date":"2023-11-10","current":-1.950969,"twenty":-2.826914,"median":-2.488481,"eighty":-2.324241,"marketCap":103161389},{"date":"2023-11-17","current":-2.256319,"twenty":-2.787099,"median":-2.463596,"eighty":-2.289402,"marketCap":103950889},{"date":"2023-11-24","current":-2.28488,"twenty":-2.783117,"median":-2.463596,"eighty":-2.279168,"marketCap":105266724},{"date":"2023-12-01","current":-2.28488,"twenty":-2.746288,"median":-2.438711,"eighty":-2.28031,"marketCap":105266724},{"date":"2023-12-08","current":-2.267744,"twenty":-2.737329,"median":-2.418803,"eighty":-2.260889,"marketCap":104477223},{"date":"2023-12-15","current":-4.5412,"twenty":-2.795062,"median":-2.431246,"eighty":-2.266602,"marketCap":209217613},{"date":"2023-12-22","current":-4.598322,"twenty":-3.021016,"median":-2.448665,"eighty":-2.281453,"marketCap":211849282},{"date":"2023-12-29","current":-4.95819,"twenty":-3.29873,"median":-2.463596,"eighty":-2.28488,"marketCap":228428791},{"date":"2024-01-05","current":-4.758263,"twenty":-3.39876,"median":-2.463596,"eighty":-2.28488,"marketCap":219217952},{"date":"2024-01-12","current":-5.032449,"twenty":-4.524063,"median":-2.488481,"eighty":-2.28488,"marketCap":231849959},{"date":"2024-01-19","current":-4.741127,"twenty":-4.602892,"median":-2.518343,"eighty":-2.28488,"marketCap":218428452},{"date":"2024-01-26","current":-5.146693,"twenty":-4.685148,"median":-2.533274,"eighty":-2.28488,"marketCap":237113295},{"date":"2024-02-02","current":-5.072434,"twenty":-4.83138,"median":-2.545716,"eighty":-2.28488,"marketCap":233692127},{"date":"2024-02-09","current":-5.489425,"twenty":-4.967529,"median":-2.592997,"eighty":-2.28488,"marketCap":252903304},{"date":"2024-02-16","current":-5.472288,"twenty":-5.007315,"median":-2.704979,"eighty":-2.288498,"marketCap":252113803},{"date":"2024-02-23","current":-5.340908,"twenty":-5.041589,"median":-2.759726,"eighty":-2.289402,"marketCap":246060967},{"date":"2024-03-01","current":-5.44944,"twenty":-5.138125,"median":-2.826914,"eighty":-2.290117,"marketCap":251061136},{"date":"2024-03-08","current":-5.50085,"twenty":-5.175254,"median":-2.964631,"eighty":-2.290593,"marketCap":253429638},{"date":"2024-03-15","current":-5.318059,"twenty":-5.209527,"median":-3.244979,"eighty":-2.301823,"marketCap":245008300},{"date":"2024-03-22","current":-5.409454,"twenty":-5.259795,"median":-3.384081,"eighty":-2.31379,"marketCap":249218969},{"date":"2024-03-28","current":-5.392318,"twenty":-5.294068,"median":-3.745164,"eighty":-2.319762,"marketCap":248429468},{"date":"2024-04-05","current":-4.384474,"twenty":-5.294068,"median":-4.384474,"eighty":-2.326776,"marketCap":258850575},{"date":"2024-04-12","current":-4.353156,"twenty":-5.276931,"median":-4.384474,"eighty":-2.338992,"marketCap":257001642},{"date":"2024-04-19","current":-4.455335,"twenty":-5.266649,"median":-4.384474,"eighty":-2.356591,"marketCap":263034039},{"date":"2024-04-26","current":-4.500658,"twenty":-5.262079,"median":-4.384474,"eighty":-2.364057,"marketCap":265709869},{"date":"2024-05-03","current":-4.233248,"twenty":-5.243801,"median":-4.375526,"eighty":-2.370029,"marketCap":249922475},{"date":"2024-05-10","current":-4.441737,"twenty":-5.217524,"median":-4.376905,"eighty":-2.392923,"marketCap":262231291},{"date":"2024-05-17","current":-4.056251,"twenty":-5.20153,"median":-4.378284,"eighty":-2.413826,"marketCap":259555461},{"date":"2024-05-24","current":-3.989344,"twenty":-5.198103,"median":-4.360154,"eighty":-2.415817,"marketCap":255274134},{"date":"2024-05-31","current":-3.157814,"twenty":-5.195818,"median":-4.356655,"eighty":-2.419798,"marketCap":202065392},{"date":"2024-06-07","current":-2.937107,"twenty":-5.185536,"median":-4.305766,"eighty":-2.426766,"marketCap":187942542},{"date":"2024-06-14","current":-2.47447,"twenty":-5.180966,"median":-4.244579,"eighty":-2.438711,"marketCap":158338876},{"date":"2024-06-21","current":-2.410805,"twenty":-5.176396,"median":-4.23778,"eighty":-2.426982,"marketCap":154264977},{"date":"2024-06-28","current":-2.44476,"twenty":-5.175254,"median":-4.233248,"eighty":-2.429968,"marketCap":156437723},{"date":"2024-07-05","current":-2.534093,"twenty":-5.175254,"median":-4.21965,"eighty":-2.42378,"marketCap":162154099},{"date":"2024-07-12","current":-2.451758,"twenty":-5.16383,"median":-4.144067,"eighty":-2.427782,"marketCap":156885554},{"date":"2024-07-15","current":-2.470055,"twenty":-5.161545,"median":-4.118977,"eighty":-2.428003,"marketCap":158056342},{"date":"2024-08-02","current":-2.653034,"twenty":-5.15926,"median":-4.087614,"eighty":-2.428224,"marketCap":169765008},{"date":"2024-08-09","current":-2.59357,"twenty":-5.15012,"median":-3.989344,"eighty":-2.432817,"marketCap":165959930},{"date":"2024-08-16","current":-3.172195,"twenty":-5.140981,"median":-3.732619,"eighty":-2.438711,"marketCap":172399292},{"date":"2024-08-23","current":-3.014909,"twenty":-5.128985,"median":-3.369403,"eighty":-2.441131,"marketCap":163851273},{"date":"2024-08-30","current":-2.82614,"twenty":-5.10328,"median":-3.274262,"eighty":-2.446322,"marketCap":153592249},{"date":"2024-09-06","current":-2.815354,"twenty":-5.069007,"median":-3.175616,"eighty":-2.448733,"marketCap":153006019},{"date":"2024-09-13","current":-2.772206,"twenty":-5.050728,"median":-3.157814,"eighty":-2.449555,"marketCap":150661099},{"date":"2024-09-20","current":-2.475569,"twenty":-5.030164,"median":-3.120622,"eighty":-2.449555,"marketCap":134539775},{"date":"2024-09-27","current":-2.249047,"twenty":-5.021025,"median":-3.067173,"eighty":-2.438711,"marketCap":122228946},{"date":"2024-10-04","current":-2.324554,"twenty":-5.017598,"median":-3.038972,"eighty":-2.428003,"marketCap":126332556},{"date":"2024-10-11","current":-2.286801,"twenty":-5.002746,"median":-3.016039,"eighty":-2.416754,"marketCap":124280751},{"date":"2024-10-18","current":-2.292194,"twenty":-4.992464,"median":-2.998729,"eighty":-2.411409,"marketCap":124573866},{"date":"2024-10-25","current":-2.216686,"twenty":-4.969615,"median":-2.913222,"eighty":-2.395748,"marketCap":120470256},{"date":"2024-10-31","current":-2.232956,"twenty":-4.969615,"median":-2.861813,"eighty":-2.364057,"marketCap":121354466},{"date":"2024-11-08","current":-2.345165,"twenty":-4.967008,"median":-2.826527,"eighty":-2.342895,"marketCap":127452680},{"date":"2024-11-15","current":-2.249787,"twenty":-4.95819,"median":-2.787099,"eighty":-2.342895,"marketCap":122269198},{"date":"2024-11-22","current":-2.44476,"twenty":-4.883932,"median":-2.767647,"eighty":-2.330578,"marketCap":135075448},{"date":"2024-11-29","current":-2.516673,"twenty":-4.856514,"median":-2.737329,"eighty":-2.330452,"marketCap":139048704},{"date":"2024-12-06","current":-2.290393,"twenty":-4.83138,"median":-2.702092,"eighty":-2.324491,"marketCap":126546518},{"date":"2024-12-13","current":-2.191051,"twenty":-4.771972,"median":-2.691305,"eighty":-2.315283,"marketCap":121057753},{"date":"2024-12-20","current":-1.986847,"twenty":-4.744554,"median":-2.685912,"eighty":-2.292194,"marketCap":109775293},{"date":"2024-12-27","current":-2.753991,"twenty":-4.72399,"median":-2.677186,"eighty":-2.292194,"marketCap":152160753},{"date":"2025-01-03","current":-2.748472,"twenty":-4.698857,"median":-2.685912,"eighty":-2.294351,"marketCap":151855822},{"date":"2025-01-10","current":-2.638092,"twenty":-4.676008,"median":-2.685912,"eighty":-2.29946,"marketCap":145757194},{"date":"2025-01-17","current":-2.665687,"twenty":-4.661727,"median":-2.685912,"eighty":-2.307422,"marketCap":147281851},{"date":"2025-01-24","current":-2.847814,"twenty":-4.641162,"median":-2.688608,"eighty":-2.30931,"marketCap":157344586},{"date":"2025-01-31","current":-2.820219,"twenty":-4.641162,"median":-2.696699,"eighty":-2.316776,"marketCap":155819930},{"date":"2025-02-07","current":-2.969233,"twenty":-4.628574,"median":-2.702092,"eighty":-2.317988,"marketCap":164053077},{"date":"2025-02-14","current":-3.052018,"twenty":-4.623033,"median":-2.70432,"eighty":-2.324241,"marketCap":168627047},{"date":"2025-02-21","current":-3.156879,"twenty":-4.621543,"median":-2.737329,"eighty":-2.324491,"marketCap":174420743},{"date":"2025-02-28","current":-3.129284,"twenty":-4.604531,"median":-2.740194,"eighty":-2.328869,"marketCap":172896086},{"date":"2025-03-07","current":-3.123765,"twenty":-4.598732,"median":-2.753991,"eighty":-2.330452,"marketCap":172591155},{"date":"2025-03-14","current":-2.925081,"twenty":-4.588306,"median":-2.764058,"eighty":-2.333271,"marketCap":161613626},{"date":"2025-03-21","current":-2.969233,"twenty":-4.553589,"median":-2.772206,"eighty":-2.33884,"marketCap":164053077},{"date":"2025-03-28","current":-5.579621,"twenty":-4.553589,"median":-2.784611,"eighty":-2.340601,"marketCap":167712253},{"date":"2025-04-04","current":-5.43444,"twenty":-4.621543,"median":-2.8147,"eighty":-2.342463,"marketCap":163277758},{"date":"2025-04-11","current":-5.777997,"twenty":-4.646303,"median":-2.820219,"eighty":-2.344711,"marketCap":173599915},{"date":"2025-04-17","current":-6.154808,"twenty":-4.72399,"median":-2.826527,"eighty":-2.349034,"marketCap":184921207},{"date":"2025-04-25","current":-6.068877,"twenty":-4.863368,"median":-2.842295,"eighty":-2.35908,"marketCap":182339410},{"date":"2025-05-02","current":-5.46736,"twenty":-4.969615,"median":-2.847814,"eighty":-2.364057,"marketCap":164266831},{"date":"2025-05-09","current":-5.574774,"twenty":-5.021025,"median":-2.861813,"eighty":-2.369553,"marketCap":167494077},{"date":"2025-05-16","current":-6.059832,"twenty":-5.092998,"median":-2.908113,"eighty":-2.37668,"marketCap":164912280},{"date":"2025-05-23","current":-6.344443,"twenty":-5.156975,"median":-2.925081,"eighty":-2.381924,"marketCap":172657671},{"date":"2025-05-30","current":-6.498607,"twenty":-5.178681,"median":-2.925081,"eighty":-2.384016,"marketCap":176853091},{"date":"2025-06-06","current":-7.424857,"twenty":-5.20153,"median":-2.941638,"eighty":-2.388398,"marketCap":202060057},{"date":"2025-06-13","current":-7.647325,"twenty":-5.265299,"median":-2.958195,"eighty":-2.396826,"marketCap":208114291},{"date":"2025-06-20","current":-7.480474,"twenty":-5.297495,"median":-2.969233,"eighty":-2.400062,"marketCap":203573615},{"date":"2025-06-27","current":-7.049443,"twenty":-5.323771,"median":-3.012212,"eighty":-2.401141,"marketCap":191843537},{"date":"2025-07-03","current":-7.049443,"twenty":-5.34662,"median":-3.022216,"eighty":-2.405455,"marketCap":191843537},{"date":"2025-07-11","current":-6.952113,"twenty":-5.392318,"median":-3.038972,"eighty":-2.410805,"marketCap":189194810},{"date":"2025-07-18","current":-6.562795,"twenty":-5.426591,"median":-3.04374,"eighty":-2.413826,"marketCap":178599900},{"date":"2025-07-25","current":-6.493274,"twenty":-5.44944,"median":-3.063056,"eighty":-2.413826,"marketCap":176707952},{"date":"2025-08-01","current":-5.881488,"twenty":-5.488843,"median":-3.076854,"eighty":-2.416242,"marketCap":160058809},{"date":"2025-08-08","current":-5.102851,"twenty":-5.492169,"median":-3.085132,"eighty":-2.418803,"marketCap":138868990},{"date":"2025-08-15","current":-6.207412,"twenty":-5.50085,"median":-3.104761,"eighty":-2.421636,"marketCap":193485042},{"date":"2025-08-22","current":-7.935249,"twenty":-5.546547,"median":-3.118246,"eighty":-2.42378,"marketCap":247341703},{"date":"2025-08-29","current":-8.175226,"twenty":-5.569396,"median":-3.121005,"eighty":-2.427782,"marketCap":254821795},{"date":"2025-09-05","current":-8.23922,"twenty":-5.585719,"median":-3.126572,"eighty":-2.428666,"marketCap":256816486},{"date":"2025-09-12","current":-7.487291,"twenty":-5.660791,"median":-3.136277,"eighty":-2.43603,"marketCap":233378865},{"date":"2025-09-19","current":-7.871255,"twenty":-5.725943,"median":-3.15136,"eighty":-2.438532,"marketCap":245347012},{"date":"2025-09-26","current":-7.615279,"twenty":-5.748846,"median":-3.157814,"eighty":-2.438711,"marketCap":237368248},{"date":"2025-10-03","current":-7.231315,"twenty":-5.817463,"median":-3.172816,"eighty":-2.44355,"marketCap":225400101},{"date":"2025-10-10","current":-7.071331,"twenty":-5.859241,"median":-3.179036,"eighty":-2.44476,"marketCap":220413373},{"date":"2025-10-17","current":-7.599281,"twenty":-6.061641,"median":-3.274262,"eighty":-2.447884,"marketCap":236869575},{"date":"2025-10-24","current":-8.207223,"twenty":-6.143089,"median":-3.369403,"eighty":-2.448936,"marketCap":255819141},{"date":"2025-10-31","current":-7.471293,"twenty":-6.154808,"median":-3.732619,"eighty":-2.451207,"marketCap":232880192},{"date":"2025-11-07","current":-7.023335,"twenty":-6.21731,"median":-3.989344,"eighty":-2.453548,"marketCap":218917354},{"date":"2025-11-14","current":-7.037001,"twenty":-6.34115,"median":-4.087614,"eighty":-2.461676,"marketCap":219343325},{"date":"2025-11-21","current":-6.261002,"twenty":-6.329204,"median":-4.218938,"eighty":-2.463596,"marketCap":247822982},{"date":"2025-11-28","current":-8.671993,"twenty":-6.359803,"median":-4.21965,"eighty":-2.463596,"marketCap":343254816},{"date":"2025-12-05","current":-8.457402,"twenty":-6.420382,"median":-4.241104,"eighty":-2.467471,"marketCap":334760883},{"date":"2025-12-12","current":-9.467241,"twenty":-6.540548,"median":-4.301233,"eighty":-2.472152,"marketCap":374732332},{"date":"2025-12-19","current":-9.189535,"twenty":-6.598221,"median":-4.346445,"eighty":-2.474102,"marketCap":363740184},{"date":"2025-12-26","current":-8.911829,"twenty":-6.831175,"median":-4.360154,"eighty":-2.47491,"marketCap":352748035},{"date":"2026-01-02","current":-8.810846,"twenty":-6.921713,"median":-4.36784,"eighty":-2.476161,"marketCap":348750890},{"date":"2026-01-09","current":-7.750515,"twenty":-6.963236,"median":-4.384474,"eighty":-2.480093,"marketCap":306780869},{"date":"2026-01-16","current":-7.763138,"twenty":-7.034268,"median":-4.384474,"eighty":-2.487435,"marketCap":307280512},{"date":"2026-01-23","current":-6.93002,"twenty":-7.023335,"median":-4.403212,"eighty":-2.49175,"marketCap":274304067},{"date":"2026-01-30","current":-6.298871,"twenty":-7.023335,"median":-4.455335,"eighty":-2.492926,"marketCap":249321911},{"date":"2026-02-06","current":-5.907558,"twenty":-7.005758,"median":-4.462101,"eighty":-2.498435,"marketCap":233832975},{"date":"2026-02-13","current":-6.021165,"twenty":-6.980512,"median":-4.524063,"eighty":-2.502257,"marketCap":238329763},{"date":"2026-02-20","current":-5.829817,"twenty":-6.975463,"median":-4.5412,"eighty":-2.50255,"marketCap":230755808},{"date":"2026-02-27","current":-8.129613,"twenty":-7.026068,"median":-4.592062,"eighty":-2.510661,"marketCap":321786354},{"date":"2026-03-06","current":-7.454858,"twenty":-7.053821,"median":-4.621171,"eighty":-2.513192,"marketCap":292431704},{"date":"2026-03-13","current":-6.407739,"twenty":-7.053821,"median":-4.634868,"eighty":-2.513357,"marketCap":251356391},{"date":"2026-03-20","current":-6.032652,"twenty":-7.049443,"median":-4.666868,"eighty":-2.513456,"marketCap":236642846},{"date":"2026-03-27","current":-6.126424,"twenty":-7.049443,"median":-4.726846,"eighty":-2.516034,"marketCap":240321233},{"date":"2026-04-02","current":-6.544268,"twenty":-7.041978,"median":-4.792537,"eighty":-2.516673,"marketCap":256712003},{"date":"2026-04-10","current":-6.622549,"twenty":-7.028801,"median":-4.883932,"eighty":-2.517899,"marketCap":259782721},{"date":"2026-04-17","current":-7.029609,"twenty":-7.029609,"median":-4.965409,"eighty":-2.521479,"marketCap":275750453},{"date":"2026-04-24","current":-7.248795,"twenty":-7.049443,"median":-4.969615,"eighty":-2.524147,"marketCap":284348463},{"date":"2026-05-01","current":-6.763454,"twenty":-7.049443,"median":-5.012456,"eighty":-2.525364,"marketCap":265310013},{"date":"2026-05-08","current":-6.98264,"twenty":-7.058198,"median":-5.032449,"eighty":-2.530288,"marketCap":273908023},{"date":"2026-05-15","current":-5.66652,"twenty":-7.071331,"median":-5.087643,"eighty":-2.533765,"marketCap":154769668},{"date":"2026-05-22","current":-7.757736,"twenty":-7.084822,"median":-5.132413,"eighty":-2.534093,"marketCap":211887045},{"date":"2026-05-29","current":-7.352985,"twenty":-7.114751,"median":-5.152405,"eighty":-2.534098,"marketCap":200832069},{"date":"2026-06-05","current":-7.420443,"twenty":-7.168128,"median":-5.175254,"eighty":-2.535763,"marketCap":202674565},{"date":"2026-06-12","current":-8.184974,"twenty":-7.19649,"median":-5.186678,"eighty":-2.540241,"marketCap":223556187},{"date":"2026-06-18","current":-8.747129,"twenty":-7.215558,"median":-5.198103,"eighty":-2.544222,"marketCap":238910321},{"date":"2026-06-26","current":-9.826466,"twenty":-7.21795,"median":-5.240945,"eighty":-2.550195,"marketCap":268390257},{"date":"2026-07-02","current":-10.028841,"twenty":-7.244102,"median":-5.264962,"eighty":-2.558158,"marketCap":273917746},{"date":"2026-07-10","current":-8.747129,"twenty":-7.264451,"median":-5.283786,"eighty":-2.559358,"marketCap":238910321},{"date":"2026-07-17","current":-9.803979,"twenty":-7.285526,"median":-5.318059,"eighty":-2.559358,"marketCap":267776092},{"date":"2026-07-24","current":-9.601604,"twenty":-7.330498,"median":-5.323771,"eighty":-2.571863,"marketCap":262248604},{"date":"2026-07-31","current":-10.253703,"twenty":-7.356109,"median":-5.340908,"eighty":-2.5819,"marketCap":280059399},{"date":"2026-08-07","current":-10.601819,"twenty":-7.399098,"median":-5.365517,"eighty":-2.587618,"marketCap":299098525},{"date":"2026-08-14","current":-12.287856,"twenty":-7.426874,"median":-5.392318,"eighty":-2.58888,"marketCap":346664998},{"date":"2026-08-21","current":-11.414829,"twenty":-7.449022,"median":-5.406598,"eighty":-2.592197,"marketCap":322035158},{"date":"2026-08-28","current":-10.760059,"twenty":-7.473129,"median":-5.43444,"eighty":-2.593455,"marketCap":303562778},{"date":"2026-08-31","current":-10.541802,"twenty":-7.480474,"median":-5.43444,"eighty":-2.59357,"marketCap":297405318}],"updateTime":1788317624592},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLSI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631524728","title":"TriSalus Chief of Clinical Operations Devlin to retire Oct. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2631524728","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631524728?lang=en_us&edition=fundamental","pubTime":"2026-04-30 05:21","pubTimestamp":1777497700,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences disclosed retirement of Jodi Devlin from role as Chief of Clinical Operations, effective Oct. 1, 2026.Company previously named Richard Marshall as Chief Medical Officer, effective June 29, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL5N7x5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631511539","title":"Press Release: TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2631511539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631511539?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:51","pubTimestamp":1777409460,"startTime":"0","endTime":"0","summary":"Conference Call and Webcast Scheduled for Tuesday, May 12, 2026 at 4:30 PM. TriSalus Life Sciences, Inc.  , an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, announced today that it will host a conference call and webcast on Tuesday, May 12, 2026 at 4:30 PM eastern time to discuss its financial results for the quarter ended March 31, 2026. A press release detailing the results will be issued prior to the call.Parties interested in participating by phone should register using this online form. After registering for the call, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. The event will also be webcast live on the investor relations section of TriSalus' website. A replay will also be available on the website following the event.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","TLSI","BK4232","TM","BK4181","HST","BK4218","R","BK4585","BK4555","BK4604","BK4099","BK4588","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631535687","title":"TriSalus Life Sciences to host first-quarter financial results conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2631535687","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631535687?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:16","pubTimestamp":1777407413,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences scheduled a first-quarter 2026 financial results conference call for May 12, 2026 at 4:30 p.m. ET.Live webcast will run via TriSalus investor relations page at .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via Business Wire  on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL82K6H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631587536","title":"Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2631587536","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631587536?lang=en_us&edition=fundamental","pubTime":"2026-04-29 02:00","pubTimestamp":1777399228,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rocket Pharmaceuticals (RCKT) and TriSalus Life Scie...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-trisalus-life-sciences-tlsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","RCKT","BK4585","BK4588","LABU","BK4137","BK4139","LU0128526141.USD","TLSI","XLV","XBI","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627233539","title":"TriSalus publishes investor presentation on pressure-enabled drug delivery for solid tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2627233539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627233539?lang=en_us&edition=fundamental","pubTime":"2026-04-15 22:32","pubTimestamp":1776263578,"startTime":"0","endTime":"0","summary":"TriSalus highlighted Pressure Enabled Drug Delivery platform TriNav for locoregional infusion into solid tumors, targeting hepatocellular carcinoma and pancreatic cancer.2026 outlook calls for annual revenues of $60 million to $62 million.U.S. addressable device market opportunity estimated at more than $2.5 billion annually.Pipeline asset nelitolimod, delivered via PEDD to liver and pancreatic tumors, framed as adding $1 billion incremental upside if approved for combination use in pancreatic cancer.Reimbursement support includes HCPCS mapping code C8004 with 2026 rate of $11,794, alongside procedure code C9797 with 2026 rate of $18,728.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL22qrDp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626313030","title":"TriSalus to present new PEDD clinical, preclinical data at SIR 2026 meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2626313030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626313030?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:08","pubTimestamp":1775765319,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences scheduled new clinical and preclinical data presentations on its Pressure Enabled Drug Delivery  platform at Society of Interventional Radiology 2026 meeting on April 11-15 in Toronto.Results will be presented in the future, with sessions set for April 13-14, 2026.Data are expected to support PEDD’s ability to improve delivery and penetration of therapies in liver-directed procedures.Separate clinical assessments are set to address safety and efficacy in embolization settings, including uterine artery embolization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via Business Wire  on April 09, 2026, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL4Z1wCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625553999","title":"TriSalus Life Sciences Appoints Richard Marshall, M.d., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625553999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625553999?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:15","pubTimestamp":1775567700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA95V3CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625805955","title":"TriSalus names Richard Marshall chief medical officer effective June 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2625805955","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625805955?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:11","pubTimestamp":1775567478,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences appointed Richard Marshall as chief medical officer on a full-time basis, effective June 29, 2026.Marshall will transition from his current role as medical director, a position he has held since January 2025.He will lead medical strategy, clinical development, evidence generation, and broader strategic initiatives.Marshall is an interventional radiologist with experience in interventional oncology and hepatobiliary interventions.He trained at Weill Cornell University and Memorial Sloan Kettering Cancer Center, then held faculty roles at Louisiana State University Health Sciences Center and Tulane University.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL4Zdgtd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624554396","title":"TriSalus Life Sciences announces annual shareholder meeting notice and proxy statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2624554396","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624554396?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:44","pubTimestamp":1775000661,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences scheduled virtual annual stockholder meeting for May 14, 2026.Shareholders set to vote on election of two Class III directors, including Mary Szela and Gary Gordon, for terms running to 2029.Advisory votes planned on say-on-pay for named executive officer compensation, plus preferred frequency for future say-on-pay votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL9BKfDK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621709365","title":"TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland","url":"https://stock-news.laohu8.com/highlight/detail?id=2621709365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621709365?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:17","pubTimestamp":1774271860,"startTime":"0","endTime":"0","summary":"Northland analyst Carl Byrnes lowered the firm’s price target on TriSalus Life Sciences (TLSI) to $8 from $12.50 and keeps an Outperform rating on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-8-from-12-50-at-northland-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-8-from-12-50-at-northland-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620025382","title":"TriSalus Life Sciences reports preclinical study of PEDD-delivered nelitolimod in liver tumor models","url":"https://stock-news.laohu8.com/highlight/detail?id=2620025382","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620025382?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:02","pubTimestamp":1773835371,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences announced the publication of a preclinical study in Frontiers in Oncology evaluating pressure-enabled drug delivery  of nelitolimod, an investigational TLR9 agonist, in liver tumor models. The study compared PEDD delivery using the TriNav Infusion System versus conventional microcatheter delivery in a porcine hepatic tumor model, and also assessed anti-tumor activity in murine liver metastasis models. Results have already been presented in the publication and showed greater distribution of nelitolimod within and around tumors with PEDD compared with a conventional microcatheter. The study also reported reduced myeloid-derived suppressor cells and increased CD8+ T-cell infiltration in the tumor microenvironment following PEDD delivery. In the murine model, nelitolimod delivered with PEDD reduced tumor growth compared with systemic administration at key study time points.Disclaimer: This news brief was created by Public Technologies  using generative artificial int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL329kFq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618203957","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618203957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618203957?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:50","pubTimestamp":1773161405,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TriSalus Life Sciences (TLSI – Research Report), Cullinan Managem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4550","IE00BLSP4239.USD","BK4139","LU0985481810.HKD","IE000M9KFDE8.USD","BK4581","IE00BLSP4452.SGD","SG9999002232.USD","LU0225284248.USD","LU0306806265.USD","LU1883839398.USD","BK4534","LU1066053197.SGD","LABU","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","CGEM","SG9999011175.SGD","IE00B19Z3581.USD","LU0058720904.USD","SG9999001176.SGD","BK4533","IE0002270589.USD","LU0321505868.SGD","LU1066051498.USD","IE00BBT3K403.USD","LU1057294990.SGD","SG9999002224.SGD","BK4568","LU0128526141.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4599","LU1894683264.USD","LU0289739699.SGD","LU0456855351.SGD","BK4585","PFE","LU0225771236.USD","SG9999013999.USD","LU0170899867.USD","LU0122379950.USD","XBI","TLSI","BK4137","LU0321505439.SGD","SGXZ57979304.SGD","BK4007","LU0234572021.USD","LU0306807586.USD","SG9999003800.SGD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618671401","title":"TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2618671401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618671401?lang=en_us&edition=fundamental","pubTime":"2026-03-10 03:57","pubTimestamp":1773086220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 15:57 ET (19:57 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617637475","title":"TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2617637475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617637475?lang=en_us&edition=fundamental","pubTime":"2026-03-07 03:38","pubTimestamp":1772825880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 14:38 ET (19:38 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617631846","title":"TriSalus Life Sciences Publishes Investor Presentation on Pressure-Enabled Drug Delivery for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617631846?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:00","pubTimestamp":1772812845,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc. released an investor presentation outlining its Pressure Enabled Drug Delivery platform and the TriNav infusion system portfolio for vascular access outside the heart and brain, with a focus on interventional radiology procedures such as liver embolization. The presentation describes product development and commercialization plans, including an estimated first-half 2026 launch for TriNav Advance, which is pending 510 clearance. The company also highlights U.S. market sizing for Pressure Enabled Drug Delivery applications totaling an estimated 2.5 billion dollars annually across indications including liver tumors, multinodular goiter, uterine fibroid embolization, genicular artery embolization, prostate embolization, and locally advanced pancreas. In addition, the presentation summarizes reimbursement coding and rates for procedures using the TriNav system, including HCPCS codes C8004 and C9797 with 2026 reimbursement rates listed. You can access the full pre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL6L7Z9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617820576","title":"TriSalus Life Sciences price target lowered to $7 from $12 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2617820576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617820576?lang=en_us&edition=fundamental","pubTime":"2026-03-06 19:55","pubTimestamp":1772798111,"startTime":"0","endTime":"0","summary":"Canaccord analyst William Plovanic lowered the firm’s price target on TriSalus Life Sciences (TLSI) to $7 from $12 and keeps a Buy rating on the sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-7-from-12-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-price-target-lowered-to-7-from-12-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617751065","title":"TriSalus posts Q4 revenue of USD 13.2 million up 60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617751065","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617751065?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:02","pubTimestamp":1772744520,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences reported Q4 2025 revenue of USD 13.2 million, up 60.0% year over year, with gross margin of 86.7% and net loss of USD 9.8 million. Adjusted EBITDA loss narrowed to USD 0.9 million. For FY 2025, revenue was USD 45.2 million, up 53.0%, with net loss attributable to common stockholders of USD 69.7 million and adjusted EBITDA loss of USD 17.2 million; cash and cash equivalents were USD 20.4 million as of Dec. 31, 2025. The company reaffirmed FY 2026 revenue guidance of USD 60 million to USD 62 million, and said it raised USD 46 million in gross proceeds in a post-quarter public offering to support growth initiatives. Business updates included the launch of the TriNav XP Infusion System, continued expansion of TriNav adoption in liver embolization and development of new applications beyond the liver, and the appointment of Michael Stansky to the board in February 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL65qDwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617972575","title":"TriSalus Life Sciences Q4 Income From Operations USD -3.271 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617972575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617972575?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX4EA15F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617940575","title":"Press Release: TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2617940575","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617940575?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:01","pubTimestamp":1772744460,"startTime":"0","endTime":"0","summary":"Reports $13.2 million i n Revenue in the Fourth Quarter, $45.2 million for Full-Year of 2025, Representing increases of 60% and 53%, respectively, Versus the Prior Year Periods. Hosting Conference Call and Webcast today at 4:30pm ET. \"During our fourth quarter and throughout 2025, we continued to deliver strong commercial performance, supported by the growing clinical adoption of our TriNav product suite and proprietary PEDD platform across a broad range of solid tumor indications,\" said Mary Szela, President and CEO of TriSalus. \"We are pleased to have exceeded our 2025 revenue guidance of 50%, delivering 53%, reflecting strong commercial execution and sustained progress on our strategic initiatives, including expansion of the TriNav platform across multiple indications beyond the liver.\". Highlights for Fourth Quarter 2025 and Recent Weeks. and sequential growth of 14% over the third quarter 2025.--  Delivered another strong commercial performance, with expanding use of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","BK4585","TM","BK4604","BK4232","BK4555","R","BK4588","BK4099","TLSI","03160"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}